Lower maintenance doses help prevent rebound while reducing drug exposure
So this has been in your practice for, I dont know, how long has it been in your practice and what have you started kind of using it for
Potential risks for non-diabetics While many users report positive outcomes, tirzepatide may cause side effects such as nausea, vomiting, diarrhea, constipation, and bloating
Semaglutide can attenuate inflammation in MASLD by downregulating the IRE1-XBP1-C/EBP (inositol-requiring transmembrane kinase/endonuclease-1-X-box binding protein 1-CCAAT/enhancer binding protein ) pathway in macrophages (Hu et al., 2024), the activation of which can increase the production of PGE 2 (Chopra et al., 2019)
The buffer system used, whether phosphate, citrate, histidine, or another buffer, also influences stability through its interaction with the peptide and its ability to maintain pH over time
10.1016/S2213-8587(25)00166-4 5 BeheraL